Can Core Laboratories (CLB) Keep the Earnings Surprise Streak Alive?
Core Laboratories (CLB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Core Laboratories (CLB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Core Laboratories (CLB) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Now the Right Time to Buy Core Laboratories After Its 14% YTD Rise?
CLB is a compelling investment in the oilfield services sector, featuring strong fundamentals, innovative technologies and a disciplined financial strategy poised for growth.
OPEC's Forecast of Peak Oil Demand: A Long Horizon Ahead
Considering OPEC's optimistic oil demand growth forecast, we recommend buying stocks like CLB, FTI and TUWOY.
Are Oils-Energy Stocks Lagging CORE LABS INC (CLB) This Year?
Here is how Core Laboratories (CLB) and Talen Energy Corporation (TLN) have performed compared to their sector so far this year.
Core Laboratories (CLB) Loses -10.14% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Core Laboratories (CLB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Here's Why Core Laboratories (CLB) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is CORE LABS INC (CLB) Stock Outpacing Its Oils-Energy Peers This Year?
Here is how Core Laboratories (CLB) and Ranger Energy (RNGR) have performed compared to their sector so far this year.
Core Laboratories (CLB) Q2 Earnings Beat & Revenues Lag
Core Laboratories (CLB) expects Reservoir Description revenues of $86.5-$89.5 million and Production Enhancement revenues of $44.5-$47.5 million for the third quarter of 2024.
Core Laboratories (CLB) Q2 Earnings Surpass Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.21 per share a year ago.
What's in Store for Core Laboratories (CLB) in Q2 Earnings?
Core Laboratories (CLB) is expected to report higher revenues from the year-ago period's level. It is also likely to have incurred higher operating expenses.
